Shares of health-care companies rose as traders bet the sector will benefit from the passage of a tax bill. AstraZeneca shares were in focus after analysts at brokerage Goldman Sachs said market assumptions about demand for the British drug company's product candidates were too optimistic, as reported earlier.
Continue Reading Below
-Rob Curran, email@example.com
(END) Dow Jones Newswires
December 13, 2017 16:22 ET (21:22 GMT)